From: Potential profile analysis of financial toxicity and its related factors among lung cancer patients
Variables | Latent profile (N [%]) | H | P | |||
---|---|---|---|---|---|---|
C1 | C2 | C3 | C4 | |||
Age, Y | Â | Â | Â | Â | 4.016 | 0.260 |
≤ 45 | 4 (26.7) | 0 (0.0) | 6 (40.0) | 5 (33.3) |  |  |
46 ~ 60 | 27 (16.3) | 12 (7.2) | 56 (33.7) | 71 (42.8) |  |  |
61 ~ 75 | 43 (20.1) | 18 (8.4) | 81 (37.9) | 72 (33.6) |  |  |
> 75 | 8 (30.8) | 3 (11.5) | 7 (26.9) | 8 (30.8) | Â | Â |
Sex | Â | Â | Â | Â | 1.279 | 0.734 |
Male | 60 (20.6) | 22 (7.5) | 100 (34.2) | 110 (37.7) | Â | Â |
Female | 22 (17.0) | 11 (8.5) | 50 (38.8) | 46 (35.7) | Â | Â |
Residence |  |  |  |  | 30.719 |  < 0.001 |
Urban | 35 (19.9) | 3 (8.0) | 43 (36.3) | 21 (37.8) | Â | Â |
Rural | 47 (14.8) | 30 (9.4) | 107 (33.5) | 135 (42.3) | Â | Â |
Medical expense insurance |  |  |  |  | 54.114 |  < 0.001 |
New Rural Cooperative Medical Insurance | 29 (11.07) | 27 (10.31) | 84 (32.06) | 122 (46.56) | Â | Â |
Medical Insurance for Urban Residents | 6 (23.0) | 2 (7.7) | 8 (30.8) | 10 (38.5) | Â | Â |
Medical Insurance for Urban Workers | 47 (35.4) | 4 (3.0) | 58 (43.6) | 24 (18.0) | Â | Â |
Employment Status |  |  |  |  | 33.716 |  < 0.001 |
On the job | 11 (19.0) | 7 (12.0) | 23 (39.7) | 17 (29.3) | Â | Â |
Retired | 45 (37.8) | 5 (4.2) | 48 (40.4) | 21 (17.6) | Â | Â |
Unemployed | 26 (10.7) | 21 (8.6) | 79 (32.4) | 118 (48.3) | Â | Â |
Education level |  |  |  |  | 27.902 |  < 0.001 |
Primary School or Below | 19 (10.9) | 17 (9.8) | 63 (36.2) | 75 (43.1) | Â | Â |
Junior High School/Technical Secondary School | 29 (19.4) | 11 (7.3) | 48 (32.0) | 62 (41.3) | Â | Â |
Minimum of Senior High School | 21 (31.3) | 4 (6.0) | 25 (37.3) | 17 (25.4) | Â | Â |
Junior College or Above | 13 (43.3) | 1 (3.3) | 14 (46.7) | 2 (6.7) | Â | Â |
Reimbursement Ratio |  |  |  |  | 60.656 |  < 0.001 |
≤ 50% | 16 (9.8) | 20 (12.2) | 47 (28.7) | 81 (49.3) |  |  |
50% ~ 75% | 27 (18.0) | 9 (6.0) | 53 (35.3) | 61 (40.7) |  |  |
> 75% | 39 (36.4) | 4 (3.7) | 50 (46.7) | 14 (13.2) | Â | Â |
Household Monthly Income/Person (Yuan) |  |  |  |  | 57.614 |  < 0.001 |
≤ 1000 | 16 (9.0) | 20 (11.3) | 49 (27.7) | 92 (52.0) |  |  |
1000 ~ 2999 | 21 (20.0) | 4 (3.8) | 42 (40.0) | 38 (36.2) |  |  |
3000 ~ 4999 | 19 (27.1) | 5 (7.1) | 27 (38.7) | 19 (27.1) |  |  |
5000 ~ 9999 | 16 (32.6) | 4 (8.2) | 24 (49.0) | 5 (10.2) |  |  |
> 10,000 | 10 (50.0) | 0 (0.0) | 8 (40.0) | 2 (10.0) | Â | Â |
Length of Cancer Diagnosis |  |  |  |  | 19.952 |  < 0.001 |
≤ 1 year | 68 (22.0) | 15 (4.9) | 119 (38.5) | 107 (34.6) |  |  |
1 ~ 5 years | 12 (12.5) | 17 (17.5) | 25 (25.8) | 43 (44.2) |  |  |
5 ~ 10 years | 2 (18.2) | 0 (0.0) | 5 (45.5) | 4 (36.3) |  |  |
> 10 years | 0 (0.0) | 1 (25.0) | 1 (25.0) | 2 (50.0) | Â | Â |
Number of Hospitalizations |  |  |  |  | 32.168 |  < 0.001 |
≤ 3 | 32 (27.4) | 2 (1.7) | 48 (41.0) | 35 (29.9) |  |  |
3 ~ 10 | 32 (19.7) | 7 (4.3) | 56 (34.6) | 67 (41.4) |  |  |
10 ~ 20 | 14 (23.7) | 9 (15.3) | 17 (28.8) | 19 (32.2) |  |  |
> 20 | 4 (4.82) | 15 (18.07) | 29 (34.94) | 35 (42.17) | Â | Â |
Pathological pattern | Â | Â | Â | Â | 1.182 | 0.757 |
Squamous Cell Carcinoma | 16 (19.0) | 6 (7.1) | 34 (40.5) | 28 (33.4) | Â | Â |
Adenocarcinoma | 38 (17.9) | 15 (7.1) | 74 (34.9) | 85 (40.1) | Â | Â |
Adenosquamous Carcinoma | 0 (0.0) | 1 (20.0) | 1 (20.0) | 3 (60.0) | Â | Â |
Other Neuroendocrine Tumors | 4 (33.3) | 1 (8.3) | 2 (16.7) | 5 (41.7) | Â | Â |
Small Cell Cancer | 24 (22.9) | 10 (9.5) | 37 (35.2) | 34 (32.4) | Â | Â |
Other | 0 (0.0.) | 0 (0.0) | 2 (66.7) | 1 (33.3) | Â | Â |
Cancer Stage | Â | Â | Â | Â | 12.765 | 0.005 |
I | 4 (30.8) | 0 (0.0) | 4 (30.8) | 5 (38.4) | Â | Â |
II | 8 (25.0) | 1 (3.1) | 16 (50.0) | 7 (21.9) | Â | Â |
III | 24 (20.7) | 6 (5.2) | 49 (42.2) | 37 (31.9) | Â | Â |
IV | 46 (17.6) | 26 (10.0) | 81 (31.2) | 107 (41.2) | Â | Â |
Distant Metastasis |  |  |  |  | 21.277 |  < 0.001 |
Yes | 47 (17.0) | 32 (11.6) | 88 (31.9) | 109 (39.5) | Â | Â |
No | 35 (24.1) | 1 (0.7) | 62 (42.8) | 47 (32.4) | Â | Â |
Chemotherapy | Â | Â | Â | Â | 0.804 | 0.849 |
Yes | 74 (19.6) | 30 (8.0) | 136 (36.1) | 137 (36.3) | Â | Â |
No | 8 (18.2) | 3 (6.8) | 14 (31.8) | 19 (43.2) | Â | Â |
Radiotherapy | Â | Â | Â | Â | 0.563 | 0.905 |
Yes | 26 (20.0) | 11 (8.5) | 43 (33.0) | 50 (38.5) | Â | Â |
No | 56 (19.2) | 22 (7.6) | 107 (36.8) | 106 (36.4) | Â | Â |
Immunotherapy | Â | Â | Â | Â | 0.900 | 0.825 |
Yes | 31 (19.7) | 13 (8.2) | 52 (32.9) | 62 (39.2) | Â | Â |
No | 51 (19.4) | 20 (7.6) | 98 (37.3) | 94 (35.7) | Â | Â |
Targeted Therapy | Â | Â | Â | Â | 7.164 | 0.067 |
Yes | 27 (17.9) | 16 (10.6) | 44 (29.1) | 64 (42.4) | Â | Â |
No | 55 (20.4) | 17 (6.3) | 106 (39.3) | 92 (34.0) | Â | Â |
Operative Treatment | Â | Â | Â | Â | 0.440 | 0.932 |
Yes | 14 (20.0) | 5 (7.1) | 223 (32.9) | 28 (40.0) | Â | Â |
No | 68 (19.4) | 28 (8.0) | 127 (36.1) | 128 (36.5) | Â | Â |
Change Life Style |  |  |  |  | 31.572 |  < 0.001 |
Yes | 62 (16.2) | 32 (8.4) | 138 (36.0) | 151 (39.4) | Â | Â |
No | 20 (52.6) | 1 (2.6) | 12 (31.6) | 5 (13.2) | Â | Â |
Change of Medical Plan |  |  |  |  | 52.499 |  < 0.001 |
Yes | 0 (0.0) | 0 (0.0) | 3 (8.1) | 34 (91.9) | Â | Â |
No | 82 (21.3) | 33 (8.6) | 147 (38.3) | 122 (31.8) | Â | Â |
Ask Others for Help |  |  |  |  | 71.446 |  < 0.001 |
Yes | 6 (3.9) | 17 (11.0) | 40 (26.0) | 91 (59.1) | Â | Â |
No | 76 (28.5) | 16 (6.0) | 110 (41.2) | 65 (24.3) | Â | Â |
Access to Medical Assistance | Â | Â | Â | Â | 3.683 | 0.298 |
Yes | 1 (11.1) | 0 (0.0) | 2 (22.2) | 6 (66.7) | Â | Â |
No | 82 (19.7) | 33 (8.0) | 150 (35.9) | 156 (36.4) | Â | Â |
Commercial Insurance | Â | Â | Â | Â | 9.125 | 0.028 |
Yes | 24 (30.4) | 4 (5.1) | 29 (36.7) | 22 (27.8) | Â | Â |
No | 58 (17.0) | 29 (8.5) | 121 (35.4) | 134 (39.1) | Â | Â |